Shareholder_NN
information_NOMZ
Dividends_NN
per_PIN
ADS_NN
Share_NN
price_NN
The_DT
table_NN
below_PLACE
sets_NN
out_PIN
the_DT
dividends_NN
per_PIN
ADS_NN
paid_VBN [WZPAST]
in_PIN
US_FPP1
dollars_NN
in_PIN
2005 2004 2003_CD
the_DT
last_JJ
five_CD
years_NN
,_,
translated_VBN [PASTP]
into_PIN
US_FPP1
dollars_NN
at_PIN
applicable_JJ
exchange_NN
rates_NN
._.
At_PIN
1st_CD
January_NN
12.22_CD
12.80_CD
11.92_CD
Year_NN
US$_$
High_JJ
during_PIN
the_DT
year_NN
15.44_CD
12.99_CD
13.90_CD
2005_CD
1.57_CD
Low_NN
during_PIN
the_DT
year_NN
11.75_CD
10.42_CD
10.00_CD
2004_CD
1.53_CD
At_PIN
31st_CD
December_NN
14.69_CD
12.22_CD
12.80_CD
2003_CD
1.39_CD
Increase_VPRT
Decrease_NN
20_CD
%_NN
5_CD
%_NN
7_CD
%_NN
2002_CD
1.24_CD
The_DT
table_NN
above_PLACE
sets_NN
out_PIN
the_DT
middle_JJ
market_NN
closing_GER
prices_NN
derived_VBN
2001_CD
1.11_CD
from_PIN
the_DT
London_NN
Stock_NN
Exchange_NN
Daily_NN
Official_NN
List_NN
._.
The_DT
companys_NN
share_VPRT
price_NN
increased_VBN [WZPAST]
by_PIN
20_CD
%_NN
in_PIN
2005_CD
from_PIN
a_DT
price_NN
of_PIN
12.22_CD
at_PIN
1st_CD
Dividend_NN
calendar_NN
January_NN
2005_CD
to_PIN
14.69_CD
at_PIN
31st_CD
December_NN
2005_CD
._.
This_DEMP
compares_VPRT
with_PIN
Fourth_JJ
quarter_NN
2005_CD
an_DT
increase_NN
in_PIN
the_DT
FTSE_NN
100_CD
index_NN
of_PIN
17_CD
%_NN
during_PIN
the_DT
year_NN
._.
Ex-dividend_NN
date_NN
15th_JJ
February_NN
2006_CD
Market_NN
capitalization_NOMZ
Record_NN
date_NN
17th_JJ
February_NN
2006_CD
The_DT
market_NN
capitalization_NOMZ
,_,
based_VBN [PASTP]
on_PIN
shares_NN
in_PIN
public_JJ
issue_NN
,_,
of_PIN
Payable_JJ
6th_JJ
April_NN
2006_CD
GlaxoSmithKline_NN
at_PIN
31st_CD
December_NN
2005_CD
was_VBD [BEMA]
85_CD
billion_CD
._.
At_PIN
that_DEMO
date_NN
GSK_NN
was_VBD [BEMA]
the_DT
fourth_JJ
largest_JJ
company_NN
by_PIN
market_NN
capitalization_NOMZ
on_PIN
the_DT
First_JJ
quarter_NN
2006_CD
FTSE_NN
index_NN
._.
Ex-dividend_NN
date_NN
10th_JJ
May_POMD
2006_CD
Record_NN
date_NN
12th_JJ
May_POMD
2006_CD
SmithKline_NN
Beecham_NN
plc_NN
Floating_VBG [WZPRES]
Rate_NN
Unsecured_NN
Payable_NN
6th_VPRT
July_NN
2006_CD
Loan_NN
Stock_NN
1990_CD
2010_CD
The_DT
loan_NN
stock_NN
is_VPRT [PASS]
not_XX0
listed_VBN
on_PIN
any_QUAN
exchange_NN
but_CC
holders_NN
may_POMD
require_VB [SUAV]
Second_JJ
quarter_NN
2006_CD
SmithKline_NN
Beecham_NN
plc_NN
to_TO
redeem_VB
their_TPP3
loan_NN
stock_NN
at_PIN
par_NN
,_,
i._FW
e._FW
1_CD
for_PIN
Ex-dividend_NN
date_NN
2nd_JJ
August_NN
2006_CD
every_QUAN
1_CD
of_PIN
loan_NN
stock_NN
held_VBN [PRIV]
,_,
on_PIN
the_DT
first_JJ
business_NOMZ
day_NN
of_PIN
March_NN
,_,
June_NN
,_,
Record_NN
date_NN
4th_JJ
August_NN
2006_CD
September_NN
and_PHC
December_NN
._.
Holders_NN
wishing_VBG [WZPRES]
to_TO
redeem_VB
all_QUAN
or_CC
part_NN
of_PIN
Payable_JJ
5th_JJ
October_NN
2006_CD
their_TPP3
loan_NN
stock_NN
should_NEMD
complete_VB
the_DT
notice_NN
on_PIN
the_DT
back_NN
of_PIN
their_TPP3
loan_NN
stock_NN
certificate_NN
and_CC
return_VB
it_PIT
to_PIN
the_DT
registrar_NN
,_,
to_TO
arrive_VB
at_PIN
least_JJ
30_CD
days_NN
Third_JJ
quarter_NN
2006_CD
before_IN
the_DT
relevant_JJ
redemption_NOMZ
date_NN
._.
Ex-dividend_NN
date_NN
1st_CD
November_NN
2006_CD
Record_NN
date_NN
3rd_CD
November_NN
2006_CD
Taxation_NOMZ
Payable_NN
4th_JJ
January_NN
2007_CD
General_NN
information_NOMZ
concerning_VBG [WZPRES]
the_DT
UK_NN
and_PHC
US_FPP1
tax_NN
effects_NN
of_PIN
share_NN
ownership_NN
is_VPRT [PASS]
set_VBN
out_PIN
in_PIN
`_``
Taxation_NOMZ
information_NOMZ
for_PIN
shareholders_NN
'_POS
on_PIN
Internet_NN
page_NN
186_CD
._.
Information_NOMZ
about_IN
the_DT
company_NN
including_VBG [WZPRES]
details_NN
of_PIN
the_DT
share_NN
price_NN
is_VPRT [BEMA]
available_PRED
on_PIN
GSKs_NN
website_VPRT
at_PIN
www_NN
._.
Dividends_NN
Information_NOMZ
made_VBD
available_JJ
on_PIN
the_DT
website_NN
does_VPRT
not_XX0
constitute_VB
part_NN
GlaxoSmithKline_NN
pays_VPRT
dividends_NN
quarterly_RB
._.
Details_NN
of_PIN
the_DT
dividends_NN
of_PIN
this_DEMO
Annual_JJ
Report_NN
._.
declared_VBN [PUBV]
,_,
the_DT
amount_NN
and_CC
the_DT
payment_NOMZ
dates_NN
are_VPRT [PASS]
given_VBN
in_PIN
Note_NN
14_CD
._.
Investor_NN
relations_NOMZ
Dividends_NN
per_PIN
share_NN
The_DT
table_NN
below_PLACE
sets_NN
out_PIN
the_DT
dividends_NN
per_PIN
share_NN
paid_VBN [WZPAST]
in_PIN
the_DT
last_JJ
five_CD
Investor_NN
Relations_NOMZ
may_POMD
be_VB [PASS]
contacted_VBN
as_IN
follows_VPRT
:_:
years_NN
._.
At_PIN
24th_JJ
February_NN
2006_CD
,_,
the_DT
number_NN
of_PIN
holders_NN
of_PIN
record_NN
of_PIN
shares_NN
in_PIN
the_DT
USA_NN
was_VBD [BEMA]
1,190_CD
with_PIN
holdings_GER
of_PIN
1,543,844_CD
shares_NN
,_,
and_ANDC
the_DT
number_NN
of_PIN
registered_VBN
holders_NN
of_PIN
the_DT
ADRs_NN
was_VBD [BEMA]
41,589_CD
with_PIN
holdings_GER
of_PIN
415,217,646_CD
ADRs_NN
._.
Certain_NN
of_PIN
these_DEMO
shares_NN
and_PHC
ADRs_NN
were_VBD [BYPA]
held_VBN [PRIV]
by_PIN
brokers_NN
or_CC
other_JJ
nominees_NN
._.
As_CONJ
a_NULL
result_NULL
the_DT
number_NN
of_PIN
holders_NN
of_PIN
record_NN
or_CC
registered_VBN
holders_NN
in_PIN
the_DT
USA_NN
is_VPRT [BEMA]
not_XX0
representative_PRED
of_PIN
the_DT
number_NN
of_PIN
beneficial_JJ
holders_NN
or_CC
of_PIN
the_DT
residence_NN
of_PIN
beneficial_JJ
holders_NN
._.
Control_NN
of_PIN
company_NN
As_IN
far_PLACE
as_RB
is_VPRT [PASS]
known_VBN [PRIV]
to_PIN
the_DT
company_NN
,_,
it_PIT
is_VPRT
not_XX0
directly_RB
or_CC
indirectly_RB
owned_VBN
or_CC
controlled_VBN
by_PIN
one_CD
or_CC
more_EMPH
corporations_NOMZ
or_CC
by_PIN
any_QUAN
government_NOMZ
._.
The_DT
company_NN
does_VPRT
not_XX0
know_VB [PRIV]
of_PIN
any_QUAN
arrangements_NOMZ
,_,
the_DT
operation_NOMZ
of_PIN
which_WDT [PIRE]
might_POMD
result_VB
in_PIN
a_DT
change_NN
in_PIN
control_NN
of_PIN
the_DT
company_NN
._.
Major_JJ
shareholders_NN
have_VPRT
the_DT
same_JJ
voting_NN
rights_NN
per_PIN
share_NN
as_IN
all_QUAN
other_JJ
shareholders_NN
._.
Substantial_JJ
shareholdings_GER
At_PIN
24th_JJ
February_NN
2006_CD
,_,
the_DT
company_NN
had_VBD [PEAS]
received_VBN
notification_NOMZ
of_PIN
the_DT
following_VBG
interests_NN
of_PIN
3_CD
%_NN
or_CC
more_EMPH
in_PIN
the_DT
shares_NN
in_PIN
issue_NN
,_,
excluding_VBG
Treasury_NN
shares_NN
:_:
BNY_NN
Nominees_NN
Limited_NN
holds_VPRT [PRIV] [THATD]
830,443,108_CD
shares_NN
representing_VBG [WZPRES]
14.26_CD
%_NN
._.
These_DEMO
shares_NN
are_VPRT [PASS]
held_VBN [PRIV]
on_PIN
behalf_NN
of_PIN
holders_NN
of_PIN
ADRs_NN
,_,
which_WDT [SERE]
evidence_NN
ADSs_NN
._.
Legal_NN
&_CC
General_NN
Investment_NOMZ
Management_NOMZ
Limited_NN
holds_VPRT [PRIV] [THATD]
212,219,375_CD
shares_NN
representing_VBG [WZPRES]
3.64_CD
%_NN
._.
Barclays_NN
PLC_NN
holds_VPRT [PRIV] [THATD]
221,114,143_CD
shares_NN
representing_VBG [WZPRES]
3.80_CD
%_NN
._.
As_IN
far_PLACE
as_RB
is_VPRT [PASS]
known_VBN [PRIV]
to_PIN
the_DT
company_NN
,_,
no_SYNE
other_JJ
person_NN
was_VBD [BEMA]
the_DT
owner_NN
of_PIN
3_CD
%_NN
or_CC
more_EMPH
of_PIN
the_DT
shares_NN
in_PIN
issue_NN
,_,
excluding_VBG
Treasury_NN
Shares_NN
of_PIN
the_DT
company_NN
._.
Directors_NN
and_PHC
Officers_NN
The_DT
interests_NN
of_PIN
the_DT
Directors_NN
and_PHC
Officers_NN
of_PIN
the_DT
company_NN
,_,
as_IN
defined_VBN
in_PIN
the_DT
Companies_NN
Act_NN
1985_CD
,_,
in_PIN
share_NN
options_NOMZ
of_PIN
the_DT
company_NN
are_VPRT [PASS]
given_VBN
in_PIN
the_DT
Remuneration_NOMZ
Report_NN
pages_NN
37_CD
to_PIN
54_CD
._.
Exchange_NN
controls_NN
and_CC
other_JJ
limitations_NOMZ
affecting_VBG [WZPRES]
security_NOMZ
holders_NN
There_EX
are_VPRT
currently_RB
no_SYNE
UK_NN
laws_NN
,_,
decrees_NN
or_CC
regulations_NOMZ
restricting_VBG [WZPRES]
the_DT
import_NN
or_CC
export_NN
of_PIN
capital_NN
or_CC
affecting_VBG
the_DT
remittance_NN
of_PIN
dividends_NN
or_CC
other_JJ
payments_NOMZ
to_PIN
holders_NN
of_PIN
the_DT
companys_NN
shares_NN
who_WP [WHSUB]
are_VPRT
non-residents_NN
of_PIN
the_DT
UK_NN
._.
There_EX
are_VPRT
no_SYNE
limitations_NOMZ
relating_VBG [WZPRES]
only_DWNT
to_PIN
non-residents_NN
of_PIN
the_DT
UK_NN
under_IN
English_NN
law_NN
or_CC
the_DT
companys_NN
Memorandum_NN
and_PHC
Articles_NN
of_PIN
Association_NOMZ
on_PIN
the_DT
right_NN
to_TO
be_VB [BEMA]
a_DT
holder_NN
of_PIN [STPR]
,_,
and_ANDC
to_TO
vote_VB [SUAV]
in_PIN
respect_NN
of_PIN [STPR]
,_,
the_DT
companys_NN
shares_NN
._.
Documents_NOMZ
on_PIN
display_NN
The_DT
Memorandum_NN
and_PHC
Articles_NN
of_PIN
Association_NOMZ
of_PIN
the_DT
company_NN
and_CC
other_JJ
documents_NOMZ
referred_VBD
to_PIN
in_PIN
this_DEMO
Annual_JJ
Report_NN
are_VPRT [BEMA]
available_PRED
for_PIN
inspection_NOMZ
at_PIN
the_DT
Registered_NN
Office_NN
of_PIN
the_DT
company_NN
._.
Publications_NOMZ
In_PIN
late_TIME
March_NN
2006_CD
GSK_NN
will_PRMD
publish_VB
on_PIN
the_DT
website_NN
its_PIT
Corporate_JJ
Responsibility_NOMZ
Report_NN
covering_VBG [WZPRES]
performance_NN
in_PIN
areas_NN
including_VBG [WZPRES]
community_NOMZ
investment_NOMZ
,_,
ethics_NN
and_PHC
integrity_NOMZ
,_,
access_NN
to_PIN
medicines_NN
,_,
R&D_NN
and_PHC
environment_NOMZ
health_NN
and_PHC
safety_NN
._.
GSK_NN
Annual_JJ
Report_NN
2005_CD
183_CD
INVESTOR_NN
INFORMATION_NOMZ
Shareholder_NN
information_NOMZ
continued_VBD
Nature_NN
of_PIN
trading_VBG
market_NN
Annual_JJ
General_NN
Meeting_VBG [WZPRES]
2006_CD
The_DT
Ordinary_NN
Shares_NN
of_PIN
the_DT
company_NN
were_VBD [PASS]
listed_VBN
on_PIN
the_DT
London_NN
Stock_NN
The_NN
Queen_NN
Elizabeth_NN
II_NN
Conference_NN
Centre_NN
,_,
17th_JJ
May_POMD
2006_CD
Exchange_NN
on_PIN
27th_JJ
December_NN
2000_CD
._.
The_DT
shares_NN
were_VBD [SPAU] [PASS]
also_RB
listed_VBN
on_PIN
the_DT
Broad_NN
Sanctuary_NN
,_,
Westminster_NN
,_,
New_NN
York_NN
Stock_NN
Exchange_NN
NYSE_NN
in_PIN
the_DT
form_NN
of_PIN
American_JJ
Depositary_NN
London_NN
SW1P_NN
3EE_NN
Shares_NN
ADSs_NN
from_PIN
the_DT
same_JJ
date_NN
._.
The_DT
Annual_JJ
General_NN
Meeting_VBG [WZPRES]
is_VPRT [BEMA]
the_DT
company_NN
's_POS
principal_JJ
forum_NN
for_PIN
The_DT
following_VBG
tables_NN
set_VBN [WZPAST]
out_PIN [STPR]
,_,
for_PIN
the_DT
periods_NN
indicated_VBD [PRIV]
,_,
the_DT
high_JJ
and_CC
communication_NOMZ
with_PIN
private_JJ
shareholders_NN
._.
In_CONJ
addition_NULL
to_PIN
the_DT
formal_JJ
low_JJ
middle_JJ
market_NN
closing_VBG [WZPRES]
quotations_NOMZ
in_PIN
pence_NN
for_PIN
the_DT
shares_NN
on_PIN
the_DT
business_NOMZ
there_EX
will_PRMD
be_VB
a_DT
presentation_NOMZ
by_PIN
the_DT
Chief_NN
Executive_NN
Officer_NN
on_PIN
London_NN
Stock_NN
Exchange_NN
,_,
and_ANDC
the_DT
high_JJ
and_PHC
low_JJ
last_JJ
reported_VBD [PUBV]
sales_NN
the_DT
performance_NN
of_PIN
the_DT
Group_NN
and_CC
its_PIT
future_JJ
development_NOMZ
._.
There_EX
will_PRMD
prices_NN
in_PIN
US_FPP1
dollars_NN
for_PIN
the_DT
ADSs_NN
on_PIN
the_DT
NYSE_NN
._.
be_VB
opportunity_NOMZ
for_PIN
questions_NOMZ
to_PIN
the_DT
Board_NN
,_,
and_ANDC
the_DT
Chairmen_NN
of_PIN
the_DT
Board_NN
's_POS
committees_NN
will_PRMD
take_VB
questions_NOMZ
on_PIN
matters_NN
relating_VBG [WZPRES]
to_PIN
those_DEMO
GlaxoSmithKline_NN
Pence_NN
per_PIN
share_NN
committees_NN
._.
High_NN
Low_NN
Investors_NN
holding_VBG [PRIV] [WZPRES]
shares_NN
in_PIN
the_DT
company_NN
through_PIN
a_DT
nominee_NN
service_NN
Quarter_NN
ended_VBD
31st_CD
March_NN
2006 1500 1424_CD
should_NEMD
arrange_VB [SUAV]
with_PIN
that_DEMO
nominee_NN
service_NN
to_TO
be_VB [PASS]
appointed_VBN
as_IN
a_DT
February_NN
2006 1500 1434_CD
corporate_JJ
representative_NN
or_CC
proxy_NN
in_PIN
respect_NN
of_PIN
their_TPP3
shareholding_GER
in_PIN
January_NN
2006 1496 1424_CD
order_NN
to_TO
attend_VB
and_PHC
vote_VB [SUAV]
at_PIN
the_DT
meeting_GER
._.
December_NN
2005 1483 1434_CD
November_NN
2005 1544 1429_CD
ADR_NN
holders_NN
wishing_VBG [WZPRES]
to_TO
attend_VB
the_DT
meeting_GER
must_NEMD
obtain_VB
a_DT
proxy_NN
from_PIN
October_NN
2005 1473 1395_CD
The_NN
Bank_NN
of_PIN
New_NN
York_NN
which_WDT [WHSUB]
will_PRMD
enable_VB
them_TPP3
to_TO
attend_VB
the_DT
meeting_GER
September_NN
2005 1442 1343_CD
and_CC
vote_VB [SUAV]
on_PIN
the_DT
business_NOMZ
to_TO
be_VB [PASS]
transacted_VBN
._.
ADR_NN
holders_NN
may_POMD
instruct_VB [SUAV] [THATD]
Quarter_NN
ended_VBD
31st_CD
December_NN
2005 1544 1395_CD
The_NN
Bank_NN
of_PIN
New_NN
York_NN
as_IN
to_PIN
the_DT
way_NN
in_PIN
which_WDT [PIRE]
the_DT
shares_NN
represented_VBD
Quarter_NN
ended_VBD
30th_JJ
September_NN
2005 1442 1308_CD
by_PIN
their_TPP3
ADRs_NN
should_NEMD
be_VB [BYPA]
voted_VBN [SUAV]
by_PIN
completing_VBG
and_PHC
returning_VBG
the_DT
voting_NN
Quarter_NN
ended_VBD
30th_JJ
June_NN
2005 1377 1201_CD
card_NN
provided_VBN [WZPAST]
by_PIN
the_DT
bank_NN
in_PIN
accordance_NN
with_PIN
the_DT
instructions_NOMZ
given_VBN
._.
Quarter_NN
ended_VBD
31st_CD
March_NN
2005 1318 1175_CD
Quarter_NN
ended_VBD
31st_CD
December_NN
2004 1222 1101_CD
Financial_NN
reporting_VBG [PUBV] [THATD] [WZPRES]
Quarter_NN
ended_VBD
30th_JJ
September_NN
2004 1209 1042_CD
Financial_NN
reporting_VBG [PUBV] [WZPRES]
calendar_NN
2006_CD
Quarter_NN
ended_VBD
30th_JJ
June_NN
2004 1201 1067_CD
Announcement_NOMZ
of_PIN
1st_CD
Quarter_NN
Results_NN
April_NN
2006_CD
Quarter_NN
ended_VBD
31st_CD
March_NN
2004 1299 1060_CD
Year_NN
ended_VBD
31st_CD
December_NN
2003 1390 1000_CD
Announcement_NOMZ
of_PIN
2nd_CD
Quarter_NN
Results_NN
July_NN
2006_CD
Year_NN
ended_VBD
31st_CD
December_NN
2002 1780 1057_CD
Announcement_NOMZ
of_PIN
3rd_CD
Quarter_NN
Results_NN
October_NN
2006_CD
Year_NN
ended_VBD
31st_CD
December_NN
2001 2032 1626_CD
Preliminary_JJ
Announcement_NOMZ
of_PIN
Annual_JJ
Results_NN
February_NN
2007_CD
Publication_NOMZ
of_PIN
Annual_JJ
Report_NN
Review_NN
March_NN
2007_CD
US_FPP1
dollars_NN
per_PIN
ADS_NN
High_NN
Low_NN
Results_NN
Announcements_NOMZ
Quarter_NN
ended_VBD
31st_CD
March_NN
2006_CD
52.77_CD
50.15_CD
Results_NN
Announcements_NOMZ
are_VPRT [PASS]
issued_VBN
to_PIN
the_DT
London_NN
Stock_NN
Exchange_NN
February_NN
2006_CD
52.15_CD
50.31_CD
and_CC
are_VPRT [BEMA]
available_PRED
on_PIN
its_PIT
news_NN
service_NN
._.
Shortly_TIME
afterwards_TIME
,_,
they_TPP3
are_VPRT
January_NN
2006_CD
52.77_CD
50.15_CD
issued_VBN
to_PIN
the_DT
media_NN
,_,
are_VPRT [PASS]
made_VBN
available_JJ
on_PIN
the_DT
website_NN
and_CC
sent_VBN
to_PIN
December_NN
2005_CD
51.97_CD
50.17_CD
the_DT
US_FPP1
Securities_NOMZ
and_PHC
Exchange_NN
Commission_NN
and_CC
the_DT
NYSE_NN
._.
November_NN
2005_CD
53.53_CD
49.16_CD
October_NN
2005_CD
52.39_CD
49.36_CD
Financial_NN
reports_NN
September_NN
2005_CD
51.28_CD
49.45_CD
The_DT
company_NN
publishes_VPRT
an_DT
Annual_JJ
Report_NN
and_CC
,_,
for_PIN
the_DT
investor_NN
not_XX0
Quarter_NN
ended_VBD
31st_CD
December_NN
2005_CD
53.53_CD
49.16_CD
needing_VBG
the_DT
full_JJ
detail_NN
of_PIN
the_DT
Report_NN
,_,
an_DT
Annual_JJ
Review_NN
._.
These_DEMP
are_VPRT [PASS]
Quarter_NN
ended_VBD
30th_JJ
September_NN
2005_CD
51.28_CD
46.47_CD
available_JJ
from_PIN
the_DT
date_NN
of_PIN
publication_NOMZ
on_PIN
the_DT
website_NN
._.
Quarter_NN
ended_VBD
30th_JJ
June_NN
2005_CD
51.40_CD
45.19_CD
The_DT
Annual_JJ
Review_NN
is_VPRT [PASS]
sent_VBN
to_PIN
all_QUAN
shareholders_NN
on_PIN
the_DT
date_NN
of_PIN
Quarter_NN
ended_VBD
31st_CD
March_NN
2005_CD
50.50_CD
44.48_CD
publication_NOMZ
._.
Shareholders_NN
may_POMD [SPAU]
also_RB
elect_VB
to_TO
receive_VB
the_DT
Annual_JJ
Report_NN
Quarter_NN
ended_VBD
31st_CD
December_NN
2004_CD
47.50_CD
41.15_CD
by_PIN
writing_VBG [PUBV]
to_PIN
the_DT
companys_NN
registrars_NN
._.
Alternatively_CONJ
shareholders_NN
may_POMD
Quarter_NN
ended_VBD
30th_JJ
September_NN
2004_CD
43.84_CD
39.04_CD
elect_VPRT
to_TO
receive_VB
notification_NOMZ
by_PIN
email_NN
of_PIN
the_DT
publication_NOMZ
of_PIN
financial_JJ
Quarter_NN
ended_VBD
30th_JJ
June_NN
2004_CD
43.50_CD
39.44_CD
reports_NN
by_PIN
registering_VBG
on_PIN
www_NN
._.
Quarter_NN
ended_VBD
31st_CD
March_NN
2004_CD
46.93_CD
39.38_CD
Year_NN
ended_VBD
31st_CD
December_NN
2003_CD
47.40_CD
32.75_CD
Copies_NN
of_PIN
previous_JJ
financial_JJ
reports_NN
are_VPRT [BEMA]
available_PRED
on_PIN
the_DT
website_NN
._.
Year_NN
ended_VBD
31st_CD
December_NN
2002_CD
50.87_CD
32.86_CD
Printed_NN
copies_NN
can_POMD
be_VB [PASS]
obtained_VBN
from_PIN
the_DT
registrar_NN
in_PIN
the_DT
UK_NN
and_CC
from_PIN
Year_NN
ended_VBD
31st_CD
December_NN
2001_CD
57.76_CD
48.80_CD
the_DT
Customer_NN
Response_NN
Center_NN
in_PIN
the_DT
USA_NN
._.
to_PIN
24th_JJ
February_NN
2006_CD
GSK_NN
Annual_JJ
Report_NN
2005_CD
184_CD
INVESTOR_NN
INFORMATION_NOMZ
Shareholder_NN
information_NOMZ
continued_VBD
Ordinary_JJ
shares_NN
The_DT
companys_NN
shares_NN
are_VPRT [PASS]
listed_VBN
on_PIN
the_DT
London_NN
Stock_NN
Exchange_NN
._.
Registrar_NN
The_NN
companys_VPRT
registrars_NN
are_VPRT
:_:
Lloyds_NN
TSB_NN
Registrars_NN
The_DT
Causeway_NN
,_,
Worthing_GER
,_,
West_NN
Sussex_NN
BN99_NN
6DA_NN
www_NN
._.
co._FW
uk_FW
Tel_NN
:_:
0870 600 3991_CD
inside_PLACE
the_DT
UK_NN
Tel_NN
:_:
44_CD
0_CD
121 415 7067_CD
outside_PLACE
the_DT
UK_NN
The_DT
registrars_NN
also_RB
provide_VPRT
the_DT
following_JJ
services_NN
:_:
GlaxoSmithKline_NN
Investment_NOMZ
Plan_NN
GlaxoSmithKline_NN
Individual_NN
Savings_GER
Account_NN
GlaxoSmithKline_NN
Corporate_NN
Sponsored_NN
Nominee_NN
Shareview_NN
service_NN
Shareview_NN
dealing_VBG [WZPRES]
service_NN
Share_NN
dealing_VBG [WZPRES]
service_NN
Hoare_NN
Govett_NN
operate_VPRT
a_DT
postal_JJ
dealing_VBG
service_NN
in_PIN
the_DT
companys_NN
ordinary_JJ
shares_NN
._.
It_PIT
enables_VPRT
investors_NN
to_TO
buy_VB
or_CC
sell_VB
shares_NN
at_PIN
competitive_JJ
commission_NN
charges_NN
._.
Further_JJ
details_NN
may_POMD
be_VB [BYPA]
obtained_VBN
by_PIN
telephoning_VBG
44_CD
0_CD
207 661 6555_NN
._.
Glaxo_NN
Wellcome_NN
and_PHC
SmithKline_NN
Beecham_NN
corporate_JJ
PEPs_NN
The_DT
Share_NN
Centre_NN
Limited_NN
Oxford_NN
House_NN
,_,
Oxford_NN
Road_NN
,_,
Aylesbury_NN
,_,
Bucks_NN
HP21_NN
8SZ_NN
Tel_NN
:_:
44_CD
0_CD
1296 414141_CD
The_DT
provision_NN
of_PIN
the_DT
details_NN
above_PLACE
is_VPRT [PASS]
not_XX0
intended_VBN [SUAV]
to_TO
be_VB [BEMA]
an_DT
invitation_NOMZ
or_CC
inducement_NOMZ
to_TO
engage_VB
in_PIN
an_DT
investment_NOMZ
activity_NOMZ
._.
Advice_NN
on_PIN
share_NN
dealing_VBG [WZPRES]
should_NEMD
be_VB [PASS]
obtained_VBN
from_PIN
a_DT
stockbroker_NN
or_CC
independent_JJ
financial_JJ
adviser_NN
._.
American_JJ
Depositary_NN
Shares_NN
The_NN
companys_VPRT
shares_NN
are_VPRT [PASS]
listed_VBN
on_PIN
the_DT
NYSE_NN
in_PIN
the_DT
form_NN
of_PIN
American_JJ
Depositary_NN
Shares_NN
and_CC
these_DEMP
are_VPRT [BYPA]
evidenced_VBN
by_PIN
American_JJ
Depositary_NN
Receipts_NN
ADRs_NN
,_,
each_QUAN
one_CD
of_PIN
which_WDT [PIRE]
represents_VPRT
two_CD
ordinary_JJ
shares_NN
._.
In_PIN
general_JJ
,_,
the_DT
NYSEs_NN
rules_NN
permit_VPRT
the_DT
company_NN
to_TO
follow_VB
UK_NN
corporate_JJ
governance_NN
practices_NN
instead_CONJ
of_NULL
those_DEMO
that_DEMP
apply_VPRT
in_PIN
the_DT
USA_NN
,_,
provided_VBD
that_DEMO
the_DT
company_NN
explains_VPRT [PUBV]
any_QUAN
significant_JJ
variations_NOMZ
._.
This_DEMO
explanation_NOMZ
is_VPRT [PASS]
provided_VBN
on_PIN
the_DT
companys_NN
website_VPRT
._.
ADR_NN
program_NN
administrator_NN
The_DT
ADR_NN
program_NN
is_VPRT [BYPA]
administered_VBN
by_PIN
:_:
The_DT
Bank_NN
of_PIN
New_NN
York_NN
Shareholder_NN
Relations_NOMZ
PO_NN
Box_NN
11258_CD
,_,
Church_NN
Street_NN
Station_NOMZ
New_NN
York_NN
NY_NN
10286-1258_CD
www_NN
._.
com_NN
Tel_NN
:_:
1_CD
877 353 1154_CD
toll_NN
free_JJ
Tel_NN
:_:
1_CD
212 815 3700_CD
outside_PLACE
the_DT
USA_NN
Customer_NN
Response_NN
Center_NN
Tel_NN
:_:
1_CD
888 825 5249_CD
toll_NN
free_JJ
The_DT
administrators_NN
also_RB
provide_VPRT
Global_JJ
BuyDIRECT_NN
,_,
a_DT
direct_JJ
ADS_NN
purchase_NN
sale_NN
and_PHC
dividend_NN
reinvestment_NOMZ
plan_NN
for_PIN
ADR_NN
holders_NN
._.
GSK_NN
Annual_JJ
Report_NN
2005_CD
185_CD
INVESTOR_NN
INFORMATION_NOMZ
